In this episode of Diagnostics Dialogues - Innovation & Insight, Dr. Pat Alagia is joined by two brilliant Quest colleagues, Senior Surgical Pathologist and Cytopathologist Dr. Elena Enbom, and Managing & Medical Director of Anatomic Pathology & Director of The Center of Excellence for Digital & AI-Empowered Pathology, Dr. Piotr Borkowski. Together they bring you an in-depth look into the future of pathology, and share how the exciting and evolving world of AI can enhance pathologists’ important task of diagnosing patients. During the chat, the doctors explore how the use of AI can help free up pathologists to tackle the most critical work for their patients. Plus, the guests illustrate the key time-saving benefits of AI usage in pathology that can improve patient outcomes by helping assess massive quantities of data in a much shorter amount of time than ever before. So press play and get ready to learn all about the amazing ways that Artificial Intelligence can aid pathologists, thus providing huge benefits to both patients and healthcare systems.

Follow Us

• Twitter @QuestDX
• Facebook @questdiagnostics
• Instagram @questdx
• YouTube @QuestDiagnosticsTV
• LinkedIn @Quest Diagnostics

Presented by Quest Diagnostics

www.questdiagnostics.com

In this installment of our two-part series on the fundamental pillars of laboratory-based diagnostic patient care, Dr. Pat Alagia is joined by two of the top minds in laboratory medicine and anatomic pathology, Dr. Hope Karnes and Dr. Darren Wheeler.

Offering a deep dive into the evolving world of pathology, they bring to light how the work of pathologists extends far beyond the microscope, spotlighting their integral roles in diagnosing patients and managing clinical laboratories. Throughout the conversation, the doctors shed light on the transformation of the patient experience in cancer treatment, detailing the shift from invasive procedures to targeted therapies made possible by smaller tissue samples and precise classification. Plus, Dr. Karnes and Dr. Wheeler illuminate the increasing significance of molecular studies in cancer diagnostics, painting a picture of a future where treatment is customized, producing better outcomes with fewer side effects. The episode is also peppered with insights on the exciting advancements of AI, digital pathology, and big data in crafting a more meticulous and hopeful approach to cancer care. So press play and get ready to learn all about the incredible value that pathologists and laboratorians provide patients, physicians, and caregivers across healthcare systems.

Follow Us

• Twitter @QuestDX
• Facebook @questdiagnostics
• Instagram @questdx
• YouTube @QuestDiagnosticsTV
• LinkedIn @Quest Diagnostics

Presented by Quest Diagnostics

www.questdiagnostics.com

Welcome to Diagnostics Dialogues - Innovation & Insight, where we are covering the hottest topics in healthcare with top researchers, doctors, and thought leaders! For this episode, Dr Pat Alagia is joined by Vice President & General Manager of Women’s and Reproductive Health at Quest Diagnostics, Kathleen Valentine, and Quest's Director and Medical Science Liaison for Women’s Health, Dr. Karen Racicot. Together, the group discusses the importance of genetic carrier and prenatal screening, as well as Quest's commitment to health equity and treating women throughout every stage of their lives. This episode is one of our favorites, so get ready for another thoughtful conversation with the brightest minds in healthcare and join us for Diagnostics Dialogues - Innovation & Insight, from Quest Diagnostics.

Follow Us

• Twitter @QuestDX
• Facebook @questdiagnostics
• Instagram @questdx
• YouTube @QuestDiagnosticsTV
• LinkedIn @Quest Diagnostics

Presented by Quest Diagnostics
www.questdiagnostics.com